Skip to main content
. 2019 Aug 30;7(3):66. doi: 10.3390/biomedicines7030066

Table 6.

Future perspectives.

OV-mediated gene therapy, incorporation of therapeutic genes
Improving tumor targeting of OVs by carrier cells
Improving T-cell costimulation by bi- or tri-specific antibodies
Improving OV targeting of immune cells by loading the cells with tri-specific antibodies
Combining OV therapy with checkpoint inhibitors
Combining OV therapy with physical modalities such as mEHT
Combining OV therapy with pharmacological modulation